We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants

Delisted

TCBPW was delisted on the 21st of March, 2025.

8 hedge funds and large institutions have $25.1K invested in TC BioPharm (Holdings) plc Warrants in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more funds holding

Funds holding: 58 (+3)

53% more capital invested

Capital invested by funds: $16.4K → $25.1K (+$8.73K)

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
KC
1
Kepos Capital
New York
$15K
NCM
2
Nantahala Capital Management
Connecticut
$7.65K
VF
3
Virtu Financial
New York
$1K +$697 +29,803 New
ACM
4
Altium Capital Management
New York
$612
UBS Group
5
UBS Group
Switzerland
$449 +$316 +13,503 +12,739%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$297 +$267 +11,406 New
AC
7
Armistice Capital
New York
$61 +$43.2K +1,844,705 +4,900%
Bank of America
8
Bank of America
North Carolina
$17 +$12 +529 New

TCBPW Hedge Fund Activity: Q4 2023 in Review

8 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q4 2023, worth a combined $25.1K — up 53% from $16.4K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TCBPW positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, adding an estimated $43.2K.

  • 8 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q4 2023, up from 5 in Q3 2023.
  • Funds reported $25.1K of TC BioPharm (Holdings) plc Warrants stock for Q4 2023, up 53% quarter-over-quarter.
  • 3 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q4 2023 and 0 closed out, a net change of +3 holders.
  • The largest TC BioPharm (Holdings) plc Warrants buyer in Q4 2023 was Armistice Capital, an estimated $43.2K added.

Based on aggregated 13F filings for Q4 2023.